Morning Alert: ArcelorMittal SA (ADR) (NYSE:MT), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Alcatel Lucent SA (ADR) (NYSE:ALU), Pfizer Inc. (NYSE:PFE), MDC Partners Inc. (NASDAQ:MDCA)

On 5 August, ArcelorMittal SA (ADR) (NYSE:MT)’s CEO Paul O’Flaherty, in an interview, said that government needs to decide if the steel industry is a weapon of choice for the country. “Do they industrialise through creating steel capacity or do they simply import.” The first option creates jobs and opportunity, the second decimates an industry and in Arcelor’s case 13,500 jobs. ArcelorMittal SA (ADR) (NYSE:MT) belongs to Basic Materials sector. Its net profit margin is -2.10% and weekly performance is 4.43%. On last trading day company shares ended up $9.42. ArcelorMittal SA (ADR) (NYSE:MT) distance from 50-day simple moving average (SMA50) is -4.30%.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) today announced financial and operational results for the quarter ended June 30, 2015. As of June 30, 2015, the Company had $122.0 million in cash and cash equivalents and held-to-maturity investments as compared to $98.6 million in cash and cash equivalents and held-to-maturity investments as of December 31, 2014. In addition, the Company had $1.1 million of restricted cash at June 30, 2015, which reflects collateral securing its lease obligations. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) shares increased 6.92% in last trading session and ended the day at $11.89. DRNA return on assets is -57.10%. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) quarterly performance is -44.23%.

Costa Rica’s ICE said Alcatel-Lucent SA (ADR) (NYSE:ALU) agreed to pay it a USD 10 million out-of-court settlement relating to a long-running lawsuit opposing the two companies. However, the deal does not put an end to criminal proceedings underway for over a decade. Alcatel Lucent SA (ADR) (NYSE:ALU) ended the last trading day at $3.59. Company weekly volatility is calculated as 1.43% and price to cash ratio as 1.56. Alcatel Lucent SA (ADR) (NYSE:ALU) showed a weekly performance of -4.01%.

Britain’s competition watchdog alleged on Thursday that U.S. drugmaker Pfizer (NYSE:PFE) and Flynn Pharma had breached competition law by ramping up the cost of an epilepsy drug used by more than 50,000 British patients. The Competition and Markets Authority (CMA) said its provisional view was that Pfizer and Flynn Pharma each abused a dominant position by charging “excessive and unfair” prices for phenytoin sodium capsules. Pfizer Inc. (NYSE:PFE) shares moved up 0.06% in last trading session and ended the day at $35.19. PFE Gross Margin is 81.30% and its return on assets is 5.30%. Pfizer Inc. (NYSE:PFE) quarterly performance is 4.25%.

MDC Partners Inc. (NASDAQ:MDCA) is opening a new chapter and looking forward after the inglorious departure of former CEO Miles Nadal on July 20. He left under the cloud of an ongoing SEC investigation which has already cost the company roughly $4 million in legal fees. MDC Partners Inc. (NASDAQ:MDCA) shares increased 18.43% in last trading session and ended the day at $19.34. MDCA Gross Margin is 33.70% and its return on assets is -2.80%. MDC Partners Inc. (NASDAQ:MDCA) quarterly performance is -6.84%.

Leave a Reply

Your email address will not be published. Required fields are marked *